Welcome to our dedicated page for ROCKET DOCTOR AI news (Ticker: AIRDF), a resource for investors and traders seeking the latest updates and insights on ROCKET DOCTOR AI stock.
Rocket Doctor AI Inc. reports developments tied to its physician-led, AI-powered healthcare technology business and its wholly owned Rocket Doctor Inc. digital health platform and marketplace. Company news commonly covers U.S. payer network agreements, state-by-state access expansion, physician services delivered through the platform, and updates to primary care, chronic disease management, preventive care, virtual urgent care, and specialist coordination.
Recurring announcements also address financial results, product and engineering capacity, equity-based compensation, clinical AI initiatives, and the Global Library of Medicine decision support system. The company’s completed acquisition of Alea Health Holdings Ltd. adds conversational AI-powered mental health capabilities to its healthcare technology profile.
Rocket Doctor AI (CSE:AIDR, OTC:AIRDF) appointed Andrew Lau, CPA, CA as Chief Financial Officer effective July 6, 2026, following its U.S. expansion that increased access to over 21 million covered lives.
The company granted Lau, consultants and employees 263,250 stock options at $0.70 per share and 319,830 RSUs, with three- to five-year terms and vesting provisions.
Rocket Doctor AI (OTC:AIRDF) entered its first U.S. value-based primary care agreement with a California independent physician association. The model uses recurring per-member-per-month payments and supports about 30,000 covered members across 9 payers and 65 plans.
The deal expands in-network access to over 5 million patients and brings Rocket Doctor’s California coverage to roughly 8.2 million covered lives, with an initial one-year term starting June 1, 2026 and automatic annual renewals.
Rocket Doctor AI (OTC:AIRDF, CSE:AIDR) entered a 12-month, automatically renewing partnership with Mindstride to provide after-hours and overflow physician coverage starting June 15, 2026.
The program uses Rocket Doctor’s network of 350+ licensed physicians to expand evening, weekend and high-demand access for eligible Mindstride patients across Ontario, Alberta and British Columbia.
Rocket Doctor AI (OTC:AIRDF) launched the first activation of its national motorsports marketing partnership with Rick Ware Racing and FinTekk AP at the inaugural Anduril 250 NASCAR Cup Series race on Naval Base Coronado.
The 2026 campaign includes ~50 motorsports activations and 14 primary races, targeting more than 21 million covered lives across the U.S., including 8.2 million eligible patients in California.
Rocket Doctor AI (OTC:AIRDF) announced that subsidiary Treatment.com, with Rush River Research, secured confirmed Year 2 NIH funding for its AI-powered, culturally responsive family medical history tool.
The Small Business Innovation Research grant totals about US$2 million, with Treatment receiving over US$500,000 through May 31, 2027 to enhance its Global Library of Medicine and clinical AI tools.
Rocket Doctor AI (CSE:AIDR, OTC:AIRDF, Frankfurt:939) granted 47,013 stock options at $0.71 per share, expiring in three years, and 514,801 RSUs with one-to-three-year terms to consultants and employees. These equity awards follow existing compensation plans, include vesting conditions, and carry a four-month-plus-one-day hold period.
The company also extended digital marketing and investor awareness services from 45 Degrees and Investment Publishing until September 30, 2026, with no additional compensation payable for the extended term.
Rocket Doctor AI (OTC:AIRDF) entered a definitive strategic marketing agreement with Rick Ware Racing and FINTEKK AP, effective June 5, 2026, focused on the 2026 NASCAR Cup Series.
The deal creates a national platform across NASCAR, NHRA, AFT and World Supercross, with exposure on NBC, FOX, USA Network, Amazon Prime, TNT Sports and HBO Max, and includes a potential future investment of up to US$5 million to support U.S. expansion beyond the more than 21 million covered lives already reached.
Rocket Doctor AI (OTC:AIRDF) reported Q1 2026 revenue of $737,103, up 5.7% quarter-over-quarter and 39.3% vs Q3 2025, with a 75% gross margin. Net loss was $4.64 million or $0.05 per share and Adjusted EBITDA loss was $2.89 million.
Cash rose to $3.5 million after a $5.2 million LIFE financing and $2.05 million in warrant exercises. U.S. covered lives expanded to about 21 million, U.S. visits grew 283% quarter-over-quarter, Canada visits increased ~25% year-over-year, and the Alea Health acquisition strengthened AI mental health capabilities.
Rocket Doctor AI (OTC:AIRDF) will host a global virtual Company Town Hall on June 3, 2026. The event, co-led by CEO Dr. Essam Hamza and Rocket Doctor founder and CEO Dr. William Cherniak, will cover 2025 milestones, Q1 2026 highlights, and U.S. growth strategy.
Rocket Doctor AI (OTC:AIRDF) entered a one-year investor relations and marketing agreement with North Star Investor Relations, effective May 15, 2026, subject to regulatory approval.
North Star will receive C$10,000 per month, no shares, options, or performance factors, and currently holds no interest in the company.